Literature DB >> 26864555

Natural Products with Antiangiogenic and Antivasculogenic Mimicry Activity.

Ying-Yun Guan, Xin Luan, Qin Lu, Ya-Rong Liu, Peng Sun, Mei Zhao1, Hong-Zhuan Chen2, Chao Fang3.   

Abstract

Angiogenesis is indispensible for tumor growth and metastasis. Antiangiogenic therapy is now a validated major strategy in cancer clinic; several small molecule angiogenic inhibitors have been successfully translated into clinic for multiple cancer indications. In the past decade, many natural products with potent antiangiogenic activity were explored and the underlying molecular mechanisms were revealed. One important mechanism is the inhibition of one or several steps in VEGF/VFGFR signaling pathway. Other factors (bFGF, HIF-1α, NF-κB etc.) capable of regulating angiogenesis, are also down-regulated by some natural products. Moreover, some of the antiangiogenic natural products also significantly inhibit vasculogenic mimicry (VM), another important vessel recruitment avenue in cancer, by regulating the key signaling of VM formation including VE-cadherin, EphA2, and Nodal signaling. In this mini-review, we summarized the natural products with suppressive effect on tumor angiogenesis and VM according to their diverse molecular mechanisms, and discussed the major direction of future research in this field.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26864555     DOI: 10.2174/1389557516666160211115507

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  4 in total

1.  Antitumor and antiangiogenic effects of Tonantzitlolone B, an uncommon diterpene from Stillingia loranthacea.

Authors:  Renata A de Abrantes; Tatianne M Batista; Vivianne M Mangueira; Tatyanna K G de Sousa; Rafael C Ferreira; Ana Paula G Moura; Lucas S Abreu; Adriano F Alves; Eudes S Velozo; Leônia M Batista; Marcelo S da Silva; Josean F Tavares; Marianna V Sobral
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-12-02       Impact factor: 3.000

Review 2.  Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.

Authors:  Khalid El Bairi; Mariam Amrani; Said Afqir
Journal:  Cancer Med       Date:  2018-05-06       Impact factor: 4.452

3.  COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis.

Authors:  Zewen Chu; Xin Shi; Gaoyang Chen; Xuejun He; Yayun Qian; Haibo Wang; Li Tao; Yanqing Liu; Wei Jiang; Jue Chen
Journal:  Front Pharmacol       Date:  2021-03-31       Impact factor: 5.810

Review 4.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.